Hospital solution for COVID-19 isolation facility.


Journal

American journal of disaster medicine
ISSN: 1932-149X
Titre abrégé: Am J Disaster Med
Pays: United States
ID NLM: 101291100

Informations de publication

Date de publication:
Historique:
entrez: 6 5 2021
pubmed: 7 5 2021
medline: 11 5 2021
Statut: ppublish

Résumé

In response to the coronavirus disease 2019 (COVID-19) pandemic, the Israeli government strategy initially focused on containment. The Ministry of Health mandated isolation of COVID-19 patients in hospitals and instructed healthcare institutions to make necessary arrangements. As the second Israeli hospital to establish a COVID-19 department, this article describes our experience in its rapid establishment, while maintaining normal medical center activities. Establishing the COVID-19 department involved planning, set-up, and implementations phases, each one based on knowledge available regarding the pandemic and established medical standards for isolation and protection of patients and staff. Wherever possible, new innovative technologies were utilized to provide maximum protection for both patients and staff, together with special online training that was developed for medical teams. A COVID-19 department was successfully established on the hospital campus, remote from other ongoing patient activities. A novel methodology of disease-adapted medicine was implemented successfully among the department's medical staff, who underwent training tailored to expected clinical scenarios. The COVID-19 department is receiving patients, with no contamination of medical personnel to date. A recent survey of COVID-19 patients revealed a very high patient satisfaction rate. Based on the experience described herein and lessons learned, the hospital is preparing for a potential large-scale COVID-19 wave, aimed at full readiness through utilization of a fortified underground emergency hospital to treat up to 900 COVID-19 patients, and establishment of versatile in-hospital infrastructure for quick conversion from standard conditions to COVID-19 appropriate conditions.

Identifiants

pubmed: 33954973
pii: ajdm.2021.0384
doi: 10.5055/ajdm.2021.0384
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

35-41

Auteurs

Gidon Berger (G)

Department of Internal Medicine "B," Rambam Health Care Campus, Haifa, Israel; Hospital Management, Ram-bam Health Care Campus, Haifa, Israel; The Ruth & Bruce Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel.

Netanel A Horowitz (NA)

Hospital Management, Rambam Health Care Campus, Haifa, Israel; Department of Hematology and Bone Marrow Transplantation, Rambam Health Care Campus, Haifa, Israel; The Ruth & Bruce Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel.

Yael Shachor-Meyouhas (Y)

Hospital Management, Rambam Health Care Campus, Haifa, Israel; The Ruth & Bruce Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel; Pediatric Infectious Disease Unit, Ruth Rappaport Chil-dren's Hospital, Rambam Health Care Campus, Haifa, Israel.

Vardit Gepstein (V)

Hospital Management, Rambam Health Care Campus, Haifa, Israel; The Ruth & Bruce Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel; Ruth Rappaport Children's Hospital, Rambam Health Care Campus, Haifa, Israel.

Khetam Hussein (K)

The Ruth & Bruce Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel; Infec-tion Control Unit, Rambam Health Care Campus, Haifa, Israel.

Avi Weismann (A)

Hospital Management, Rambam Health Care Campus, Haifa, Israel; The Ruth & Bruce Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel.

Gila Hyams (G)

Nursing Management, Rambam Health Care Campus, Haifa, Israel.

Yuval Geffen (Y)

Hospital Management, Rambam Health Care Campus, Haifa, Israel; Division of Clinical Laboratories, Rambam Health Care Campus, Haifa, Israel.

Michal Mekel (M)

Hospital Management, Rambam Health Care Campus, Haifa, Israel; The Ruth & Bruce Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel.

Michael Halberthal (M)

Hospital Management, Rambam Health Care Campus, Haifa, Israel; The Ruth & Bruce Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel. ORCID: https://orcid.org/0000-0003-3172-7619.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH